Integra Lifesciences Holdings Corp
IART- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0000917520
No open-market purchases or sales by Integra Lifesciences Holdings Corp insiders were filed in the last 90 days; 212 institutions reported holding it in 13F filings for Q2 2026, worth $1.32B in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Integra Lifesciences Holdings Corp as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 263
- −18 vs. Q2 2023
- Shares held
- 68.6M
- −519.1K (−0.8%) vs. Q2 2023
- Total value
- $2.63B
- −$221.2M (−7.8%) vs. Q2 2023
- New holders
- 33
- 81 more added
- Sold out
- 51
- 114 more reduced
2 institutions that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IART on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 212 | $1.32B |
| Q1 2026 | 202 | $704.7M |
| Q4 2025 | 205 | $919.4M |
| Q3 2025 | 207 | $1.04B |
| Q2 2025 | 209 | $896.9M |
| Q1 2025 | 220 | $1.62B |
| Q4 2024 | 223 | $1.57B |
| Q3 2024 | 225 | $1.24B |
| Q2 2024 | 238 | $2.07B |
| Q1 2024 | 281 | $2.34B |
| Q4 2023 | 284 | $2.92B |
| Q3 2023 | 263 | $2.63B |
| Q2 2023 | 283 | $2.85B |
| Q1 2023 | 280 | $4.18B |
| Q4 2022 | 281 | $4.20B |
| Q3 2022 | 282 | $3.13B |
| Q2 2022 | 285 | $3.95B |
| Q1 2022 | 278 | $4.80B |
| Q4 2021 | 277 | $5.19B |
| Q3 2021 | 262 | $5.27B |
| Q2 2021 | 264 | $5.10B |
| Q1 2021 | 257 | $5.10B |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Integra Lifesciences Holdings Corp; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Sherbrooke Park Advisers LLC | 0 | $0 | 0.00% | −5,512−100.0% | Sold out |
| Burgundy Asset Management Ltd. | 0 | $0 | 0.00% | −5,206−100.0% | Sold out |
| JustInvest LLC | 0 | $0 | 0.00% | −5,193−100.0% | Sold out |
| Pinebridge Investments, L.P. | 0 | $0 | 0.00% | −4,072−100.0% | Sold out |
| Coppell Advisory Solutions LLC | 0 | $0 | 0.00% | −2,068−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −1,092−100.0% | Sold out |
| DuPont Capital Management Corp | 0 | $0 | 0.00% | −1,039−100.0% | Sold out |
| First PREMIER Bank | 0 | $0 | 0.00% | −300−100.0% | Sold out |
| Elequin Capital LP | 0 | $0 | 0.00% | −90−100.0% | Sold out |
| Plante Moran Financial Advisors, LLC | 0 | $0 | 0.00% | −31−100.0% | Sold out |
| Sofos Investments, Inc. | 0 | $0 | 0.00% | −41−100.0% | Sold out |
| Disciplined Investments, LLC | 0 | $0 | 0.00% | −13−100.0% | Sold out |
| Farther Finance Advisors, LLC | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Capital Advisors, Ltd. LLC | 0 | $0 | 0.00% | −9−100.0% | Sold out |
| Pictet Asset Management SA | – | – | – | – | Not filed |
| First Capital Advisors Group, LLC. | – | – | – | – | Not filed |